Neupogen and Aricept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neupogen (filgrastim) and Aricept (donepezil hydrochloride). Common drug interactions include haemoglobin decreased among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Neupogen and Aricept. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

What is Aricept?

Aricept has active ingredients of donepezil hydrochloride. It is often used in alzheimer's disease. eHealthMe is studying from 24,756 Aricept users. Check the latest studies of Aricept.

On Jul, 11, 2026

14 people who take Neupogen and Aricept together, and have interactions are studied.

What are the common drug interactions of Neupogen and Aricept, by gender? *:

female:

Haemoglobin decreased
Platelet count decreased
Abdominal pain
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
Oedema peripheral (superficial swelling)
Psychotic disorder
Septic shock (shock due to blood infection)
Weight increased

male:

Death
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bone pain
Decreased appetite
Diarrhoea haemorrhagic (bloody diarrhoea)
Dizziness
Dyspnoea (difficult or laboured respiration)
Epigastric discomfort
Faeces discoloured
Fatigue (feeling of tiredness)

What are the common drug interactions of Neupogen and Aricept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anxiety
Base excess increased
Blood bilirubin increased
Blood chloride increased
Blood glucose increased
Blood osmolarity increased
Blood ph increased
Blood potassium decreased
Blood pressure increased
Blood sodium increased

40-49:

Breast cancer metastatic
Haemoglobin decreased
Malignant neoplasm progression (cancer tumour came back)
Metastases to bone marrow (cancer spreads to bone marrow)

50-59:

n/a

60+:

Haemoglobin decreased
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Weight increased
White blood cell count decreased
Abdominal discomfort
Abdominal distension
Abdominal pain upper
Angiopathy (generic term for a disease of the blood vessels)
Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
Asthenia (weakness)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 3 people, 21.43%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 14.29%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 14.29%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 7.14%
Malignant Lymphoid Neoplasm (malignant growth or tumour caused by abnormal and uncontrolled cell division in lymph node): 1 person, 7.14%
Leukopenia (less number of white blood cells in blood): 1 person, 7.14%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.14%
Breast Cancer Metastatic: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Neupogen and Aricept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously